Mehboob I Vora Do Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1755 E 61st St N, Park City, KS 67219 Phone: 316-744-7405 Fax: 316-744-7756 |
News Archive
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) announced overall survival (OS) for tivozanib, an investigational agent, from the Phase 3 TIVO-1 (TIvozanib Versus sOrafenib in 1st line advanced RCC) study in patients with advanced renal cell carcinoma (RCC). The final OS analysis, as specified by the protocol, shows a median OS of 28.8 months (95% confidence interval [CI]: 22.5–NA) for tivozanib versus a median OS of 29.3 months (95% CI: 29.3–NA) for the comparator arm, sorafenib.
Bluegiga Technologies announced today the availability of their new Bluegiga eHealth Access Point based on Bluetooth Health Device Profile (HDP). The new technology can be utilised in various health and medical applications.
A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
State lawmakers in Maryland on Thursday presented an additional $440 million in cuts from the state budget proposed by Gov. Martin O'Malley (D), including $32 million in cuts from Medicaid spending, the Washington Times reports.
PHOTONICS+ Virtual Exhibition and Conference, in partnership with EPIC (European Photonics Cluster), will take place for the second time on June 29th + 30th, 2021 at 13:00 – 17:00 CEST timezone. The soft opening of the platform is scheduled for June 8th.
› Verified 9 days ago